Fundz

Santersus AG raises Series A funding led by Norcliffe, with participation from Terumo Ventures to advance NucleoCapture for sepsis treatment.

RECENTLY ACQUIREDDec 01, 2025

Round Type

Series A

ZurichBiotechnologyHealth CareMedicalTherapeutics

Investors

Terumo VenturesNorcliffe

Description

Santersus AG has successfully completed its Series A financing, which will support NucleoCapture's advancement into pivotal clinical development. The financing was led by Norcliffe with participation from Terumo Ventures. This funding aims to address the critical need for treatment options for sepsis. Santersus has also entered a strategic collaboration with Terumo Blood and Cell Technologies for the development of the NucleoCapture device.

Quick answer

Santersus AG raised an undisclosed amount in a Series A round, dated December 1, 2025. Investors: Terumo Ventures and Norcliffe. Santersus AG is based in Zurich, Zurich, Switzerland.

How much did Santersus AG raise?
Santersus AG raised an undisclosed amount in a Series A round on December 1, 2025.
Who invested in Santersus AG?
Terumo Ventures and Norcliffe are named as investors in this round.
What does Santersus AG do?
Zurich-based Santersus AG is a biotechnology company developing NucleoCapture, a novel, patent-protected extracorporeal blood purification technology designed to selectively remove cell-free DNA (cfDNA) and neutrophil..
Where is Santersus AG based and how big is it?
Santersus AG is based in Zurich, Zurich, Switzerland. Fundz records about 7 employees.
Who are the decision-makers at Santersus AG?
Fundz holds 1 contact at Santersus AG, including the Co-Founder, Non-executive Chairman. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Santersus AG that raised within 45 days of this round, from Fundz verified event records.

  • Vivere Oncotherapies raised $10M (Funding Round) on January 13, 2026.
  • MAIA Biotechnology raised $1.5M on December 22, 2025.
  • Tivic raised $12M on December 10, 2025.
  • Tivic raised $16M on December 10, 2025.
  • Citius Oncology raised $18M (Funding Round) on December 9, 2025.
  • Aethlon Medical raised $2.2M on December 8, 2025.

Who to call at Santersus AG, and when

A new round usually means Santersus AG is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Santersus AG raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Santersus AG, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Santersus AG. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Santersus AG

Location

Zurich, Zurich, Switzerland

About

Zurich-based Santersus AG is a biotechnology company developing NucleoCapture, a novel, patent-protected extracorporeal blood purification technology designed to selectively remove cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs). The company is focused on advancing NucleoCapture for various critical medical needs including sepsis, systemic lupus erythematosus, solid-organ transplantation, and Alzheimer's disease. Santersus aims to transition towards a multi-indication, late-stage clinical development company. Its technologies are positioned to address serious unmet medical needs across various fields.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Santersus AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsScott M., Co-Founder, Non-executive ChairmanSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Santersus AG's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Santersus AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.